ArticleBMC infectious diseases2026

Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China.

Liang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.